Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Brain Pathology (Zurich, Switzerland)
|
June 25, 2016
Fatal familial insomnia: mitochondrial and protein synthesis machinery decline in the mediodorsal thalamus
Margalida A Frau-Méndez, Iván Fernández-Vega, Belén Ansoleaga, et al.
Biomolecules
|
May 7, 2020
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
Óscar López-Pérez, Marcos Bernal-Martín, Adelaida Hernaiz, et al.
Alzheimer'S Research & Therapy
|
January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers
Peter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Journal of Neuropathology and Experimental Neurology
|
March 11, 2015
Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species
Irene López-González, Agatha Schlüter, Ester Aso, et al.
Journal of Neurology
|
May 7, 2020
A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia
Daniela Diaz-Lucena, Geòrgia Escaramis, Anna Villar-Piqué, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 13, 2018
Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease
Eirini Kanata, Ewa Golanska, Anna Villar-Piqué, et al.
Biomolecules
|
December 5, 2019
Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
Inga Zerr, Anna Villar-Piqué, Vanda Edit Schmitz, et al.
Translational Neurodegeneration
|
February 27, 2021
Ecto-GPR37: a potential biomarker for Parkinson's disease
Xavier Morató, Paula Garcia-Esparcia, Josep Argerich, et al.
Nature Protocols
|
October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases
Matthias Schmitz, Maria Cramm, Franc Llorens, et al.
Frontiers in Neurology
|
March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
Paula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Brain Pathology (Zurich, Switzerland)
|
June 25, 2016
Fatal familial insomnia: mitochondrial and protein synthesis machinery decline in the mediodorsal thalamus
Margalida A Frau-Méndez, Iván Fernández-Vega, Belén Ansoleaga, et al.
Biomolecules
|
May 7, 2020
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
Óscar López-Pérez, Marcos Bernal-Martín, Adelaida Hernaiz, et al.
Alzheimer'S Research & Therapy
|
January 14, 2022
Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers
Peter Hermann, Anna Villar-Piqué, Matthias Schmitz, et al.
Journal of Neuropathology and Experimental Neurology
|
March 11, 2015
Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species
Irene López-González, Agatha Schlüter, Ester Aso, et al.
Journal of Neurology
|
May 7, 2020
A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia
Daniela Diaz-Lucena, Geòrgia Escaramis, Anna Villar-Piqué, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 13, 2018
Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease
Eirini Kanata, Ewa Golanska, Anna Villar-Piqué, et al.
Biomolecules
|
December 5, 2019
Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
Inga Zerr, Anna Villar-Piqué, Vanda Edit Schmitz, et al.
Translational Neurodegeneration
|
February 27, 2021
Ecto-GPR37: a potential biomarker for Parkinson's disease
Xavier Morató, Paula Garcia-Esparcia, Josep Argerich, et al.
Nature Protocols
|
October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases
Matthias Schmitz, Maria Cramm, Franc Llorens, et al.
Frontiers in Neurology
|
March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
Paula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Page
of 12